Bristol-Myers Squibb Co. (BMY) Stock Price

BMYStock
$67.92+40.40%52W
Market Cap$138.74B
P/E18.70x
PEG Ratio2.37
Div yield4.58%
Beta0.18

BMY Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)1.39%
Price vs S&P 500 (4W)2.73%
PEG Ratio2.37
VGM Score65.77
P/E Ratio (Annual)18.70x
Indicated Dividend Yield (Annual)4.58%

BMY Earnings Surprise History

Q2 251.46est. 1.10
Q3 251.63est. 1.52
Q4 251.26est. 1.20
Q1 261.58est. 1.42
Q2 262.04est. 1.60

BMY Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.53
3.50
3.51
3.51

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
BMYBristol-Myers Squibb Co.
BBB$67.92
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Bristol-Myers Squibb Co.

Bristol Myers Squibb is a biopharmaceutical company with leading capabilities in immuno-oncology and a broad portfolio spanning cardiovascular, oncology, and immunology therapies. The company is heavily concentrated in the US market, which accounts for approximately 70% of revenues—above the industry average.